Skip to content

Clinical study of dexmedetomidine on postoperative cognitive dysfunction in elderly patients under eyemovement combined with cerebral oxygen monitoring

Clinical study of dexmedetomidine on postoperative cognitive dysfunction in elderly patients under eyemovement combined with cerebral oxygen monitoring

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600132069
Enrollment
Unknown
Registered
2026-09-09
Start date
2026-09-25
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Neurocognitive Disorder

Interventions

Experimental group:Dexmedetomidine

Sponsors

The First People's Hospital of Zunyi
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >= 65 years; 2.ASA physical status ?-?; 3.Elective total knee arthroplasty under general anesthesia; 4.With operation duration between 1 hour and 3 hours; 5.Preoperative MMSE score >= 24 points; 6.No alcohol or drug dependence; 7.No psychiatric disorders; 8.Capable of completing postoperative follow-up and assessments; 9.Able to cooperate with eye-movement test and scale evaluation; 10.Informed consent obtained from patients and their families.

Exclusion criteria

Exclusion criteria: 1.MMSE score 24 points; 2.Confirmed dementia, Parkinson’s disease, history of psychiatric diseases, organic lesions of the central nervous system; 3.Severe audiovisual impairment precluding examinations (hearing/language disorders, illiteracy, organic ocular lesions, inability to complete neuropsychological scale assessment); 4.Severe hepatic or renal failure, cardiac insufficiency; 5.Abnormal coagulation function; 6.longterm use of sedatives or antipsychotic drugs; 7.Emergency surgery; 8.Operation duration 1 h or 3 h; 9.Anticipated massive intraoperative hemorrhage (20 % of blood volume); 10.Incomplete clinical data;Subjects withdrawing from the study midway.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative cognitive dysfunction at 24 h postoperatively assessed by MMSE scale;

Secondary

MeasureTime frame
Montreal Cognitive Assessment (MoCA) score;Generalized Anxiety Disorder-7 (GAD-7) score;Brief Pain Inventory-Short Form (BPI-SF) score;Bilateral prefrontal regional cerebral oxygen saturation (rSO2);Number of cases and duration of cerebral oxygen desaturation events;Serum concentrations of IL-6, TNF-a, sTREM2 and NfL;Intraoperative vital signs (blood pressure, heart rate, pulse oxygen saturation);Eye movement parameters of prosaccade, antisaccade and memory-guided saccade tasks;

Countries

China

Contacts

Public ContactJinqing Tang

The First People's Hospital of Zunyi

1428794327@qq.com+86 18798120459

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026